About the role
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
Mavericks Wanted
When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on
In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible.
Together we define white space, push boundaries and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work.
What You'll Do
The AD/Director, Clinical Operations is responsible for oversight and management of clinical program(s) and functional activities as assigned. This position will require you to function as a cross-functional study team lead in a fast-paced environment for the clinical development program. This role should demonstrate strong matrix management skills, confidence in working independently and have proven ability to champion a team to deliver on key study milestones.
Responsibilities
Represent Clinical Operations at the Clinical Development Team, cross-functionally and/or Global Program Team
Study Planning and Management;
Establish and coordinate all on-going study management activities, including leading the cross-functional study team to develop an overall study execution plan to deliver on key study deliverables
Partners closely and effectively with other functions and functional heads to drive program forward
Demonstrates ability to successfully manage and deliver clinical trials from start-up through close-out, including all financial tracking, metrics and reporting activities
02 Aplyr's read
BridgeBio Pharma is a dynamic biotechnology firm dedicated to tackling genetic diseases and cancers, attracting professionals passionate about impactful medical advancements.
What's promising
- •BridgeBio focuses on innovative treatments for genetic diseases, offering significant potential for groundbreaking medical advancements.
- •The company has a robust pipeline with multiple late-stage clinical trials, indicating strong future growth prospects.
- •BridgeBio's strategic partnerships enhance its research capabilities and expand its therapeutic reach.
What to watch
- •The company faces high financial risk due to significant R&D expenditures without guaranteed success.
- •BridgeBio operates in a highly competitive market with numerous established players.
- •Regulatory hurdles for drug approvals can delay product launches and impact revenue.
Why BridgeBio Pharma
- •BridgeBio's focus on genetic diseases and cancers sets it apart in the biotechnology sector.
- •The company's decentralized model allows for nimble and efficient project management.
- •BridgeBio's commitment to rare diseases addresses unmet medical needs, differentiating its mission.
Aplyr’s read is generated by AI from public sources. Was it useful?
03 About BridgeBio Pharma
BridgeBio is a biotechnology company focused on developing and commercializing medicines for genetic diseases and cancers.
04 Similar roles
Associate Director - Key Account Management Neuroscience, COBENFY Central CA, Hawaii, and Las Vegas NV
Bristol-Myers Squibb
Medical Science Liaison / Senior Medical Science Liaison, Pumitamig, International Markets, India and Thailand
Bristol-Myers Squibb
Disease Area Specialist, Clinical Trial & Pipeline
Bristol-Myers Squibb
Concierge Agent
Four Seasons
Registered Nurse RN New Graduate Cardiac PCU
Banner Health
Dialysis Clinical Manager Registered Nurse - RN
Fresenius Medical Care